Evidence map›Paper›PMID 22935166›Full record

ArticleThe British journal of nutrition2013

Antioxidant status and its association with elevated depressive symptoms among US adults: National Health and Nutrition Examination Surveys 2005-6.

May A Beydoun, Hind A Beydoun, Adel Boueiz, Monal R Shroff, Alan B Zonderman

Open access · bronzeAbstract read
In one paragraph

Article in The British journal of nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. The Relationship between FAntioxidants (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Nutrition and Lifestyle Intervention on Mood and Neurological Disorders.Journal of evidence-based complementary & alternative medicine · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

May A BeydounNIH Biomedical Research Center, National Institute on Aging, IRP, 251 Bayview Boulevard, Baltimore, MD 21224, USA.
Hind A Beydoun
Adel Boueiz
Monal R Shroff
Alan B Zonderman
Eastern Virginia Medical School · USJohns Hopkins University · USNational Institute on Aging · USUniversity of Michigan–Ann Arbor · US

Funding

Behavioral epidemiology of healthy agingZIAAG000199 · NIA · NATIONAL INSTITUTE ON AGING · PI ZONDERMAN, ALAN B · 2013 to 2019
$7.8M
Health disparities in cognitive performance across the life spanZIAAG000194 · NIA · NATIONAL INSTITUTE ON AGING · PI ZONDERMAN, ALAN B · 2009 to 2012
$2.9M
Health disparities in cognitive performance across the life spanZ01AG000194 · NIA · NATIONAL INSTITUTE ON AGING · PI ZONDERMAN, ALAN B · 2008 to 2008
$703k
AGING TRAINING GRANTT32AG000194 · NIA · YESHIVA UNIVERSITY · PI HAMERMAN, DAVID · 1989 to 1998
–
Intramural NIH HHS Z01 AG000194NIA NIH HHS T32 AG000194
6 · The paper itself

Abstract

We examined the relationship of elevated depressive symptoms with antioxidant status. Cross-sectional data from the National Health and Nutrition Examination Surveys 2005–6 on US adults aged 20–85 years were analysed. Depressive symptoms were measured using the Patient Health Questionnaire with a score cut-off point of 10 to define ‘elevated depressive symptoms’. Serum antioxidant status was measured by serum levels of carotenoids, retinol (free and retinyl esters), vitamin C and vitamin E. The main analyses consisted of multiple logistic and zero-inflated Poisson regression models, taking into account sampling design complexity. The final sample consisted of 1798 US adults with complete data. A higher total serum carotenoid level was associated with a lower likelihood of elevated depressive symptoms with a reduction in the odds by 37 % overall with each sd increase in exposure, and by 34 % among women (P< 0·05). A dose–response relationship was observed when total serum carotenoids were expressed as quartiles (Q4 (1·62–10·1 μmol/l) v. Q1 (0·06–0·86 μmol/l): OR 0·41; 95 % CI 0·23, 0·76, P< 0·001; P for trend = 0·035), though no significant associations were found with the other antioxidant levels. Among carotenoids, β-carotene (men and women combined) and lutein+zeaxanthins (women only, after control for dietary lutein+zeaxanthin intake and supplement use) had an independent inverse association with elevated depressive symptoms among US adults. None of the other serum antioxidants had a significant association with depressive symptoms, independently of total carotenoids and other covariates. In conclusion, total carotenoids (mainly β-carotene and lutein+zeaxanthins) in serum were associated with reduced levels of depressive symptoms among community-dwelling US adults.

Indexed as

AdultAgedAged, 80 and overAntioxidantsCarotenoidsDepressionFemaleHumansLikelihood FunctionsMaleMiddle AgedNutrition SurveysPoisson DistributionUnited StatesYoung AdultAntioxidantsCarotenoids

Identifiers

PMID22935166
PMCPMC3810278
OpenAlexW2141166246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.